Canadian Biotech Industry Recognizes Top Performers

Canadian Biotech Industry Recognizes Top Performers

September 28, 2022 [OTTAWA] – BIOTECanada is pleased to announce the 2022 winners in four BIOTECanada Gold Leaf Award categories- Established Biotech Company of the Year, Game Changing Industry Leadership, Ecosystem Builder, and Promising Health Biotech Company of the Year.

  • Established Biotech Company of the Year – AbCellera 
  • Game Changing Industry Leadership – Dr. Thomas Madden, President & CEO, Acuitas Therapeutics Inc 
  • Ecosystem Builder – adMare BioInnovations
  • Promising Health Biotech Company of the Year – Inversago Pharma 
  • The Gold Leaf Awards celebrate innovation and entrepreneurship within the Canadian biotech industry across all industry categories including health, agricultural, industrial and environmental biotechnology. 

“Canadian biotech companies have truly taken to the stage over the past year as demonstrated by their growth and the global recognition of their technologies and innovations. This year’s Gold Leaf award winners are representative of a larger group of phenomenal companies whose teams are driving Canadian innovation and solutions into the global market to help heal, fuel, and grow. All Canadians should be both proud and encouraged by the innovations coming from Canada’s biotech ecosystem which we celebrate through these awards,” commented Andrew Casey, President, and CEO BIOTECanada.

The Gold Leaf Awards will be presented during a ceremony at BIONATION in Ottawa Wednesday September 28, 2022. 

BIOTECanada is the national industry association and voice with over 240 members of the biotechnology ecosystem located nationwide, reflecting the diverse nature of Canada’s health, industrial and agricultural biotechnology sectors. With unprecedented global issues including the climate crisis, food sustainability and human health needs, the biotechnology industry can play a pivotal role in solving challenges while delivering significant economic benefits, including investment and employment. 

For more information:
Nadine Lunt 
613-793-6338
Nadine.lunt@biotech.ca 

 

back